The FDA also raised concerns about contamination, incorrect dosages, unapproved or harmful ingredients, and counterfeit components in compounded GLP-1s
Plaintiffs describe suffering from persistent, debilitating symptoms that persisted even after discontinuing the medication, leaving them with long-term, potentially permanent complications
VK0214, oral TR agonist for X-linked adrenoleukodystrophy (X-ALD) Recent Highlights: In June 2026, Viking announced that its working toward maintenance-dosing data for subcutaneous VK2735 and preparing to start Phase 3 trials of the oral tablet in Q4 2026, with the goal of becoming the first company to offer a dual GLP-1/GIP agonist in both oral and injectable form
Advocate for Yourself: Dont be afraid to speak up if you have concerns or if something doesnt seem right
Study Results Seven cohort studies that included over 40,000 pregnancies exposed to GLP-1 receptor agonists satisfied the criteria for quantitative assessment
In that study, 93% of adverse events associated with oral semaglutide use were the development of nonproliferative DR, and 76% required no intervention
